These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18840152)

  • 61. On assessing the presence of evaluation-time bias in progression-free survival in randomized trials.
    Kay R; Wu J; Wittes J
    Pharm Stat; 2011; 10(3):213-7. PubMed ID: 20568099
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Doubly randomized delayed-start design for enrichment studies with responders or nonresponders.
    Liu Q; Lim P; Singh J; Lewin D; Schwab B; Kent J
    J Biopharm Stat; 2012; 22(4):737-57. PubMed ID: 22651112
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Minimizing bias in randomized trials: the importance of blinding.
    Psaty BM; Prentice RL
    JAMA; 2010 Aug; 304(7):793-4. PubMed ID: 20716744
    [No Abstract]   [Full Text] [Related]  

  • 64. Trends in worldwide volume and methodological quality of surgical randomized controlled trials.
    Ahmed Ali U; van der Sluis PC; Issa Y; Habaga IA; Gooszen HG; Flum DR; Algra A; Besselink MG
    Ann Surg; 2013 Aug; 258(2):199-207. PubMed ID: 23774315
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bias and trials stopped early for benefit.
    Goodman S; Berry D; Wittes J
    JAMA; 2010 Jul; 304(2):157; author reply 158-9. PubMed ID: 20628126
    [No Abstract]   [Full Text] [Related]  

  • 66. [Clinical trials in orthopedic and trauma surgery: randomized or non-randomized?].
    Stengel D; Bauwens K; Ekkernkamp A
    Unfallchirurg; 2003 Apr; 106(4):294-9. PubMed ID: 12719849
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bias and trials stopped early for benefit.
    Korn EL; Freidlin B; Mooney M
    JAMA; 2010 Jul; 304(2):157-8; author reply 158-9. PubMed ID: 20628125
    [No Abstract]   [Full Text] [Related]  

  • 68. Equipoise, design bias and randomized controlled trials: the elusive ethics of new drugs--a comment.
    Schimetta W; Poelz G; Poelz W; Haring HP; Aichner F
    Arthritis Res Ther; 2004 Nov; 7(1):E2. PubMed ID: 15642128
    [No Abstract]   [Full Text] [Related]  

  • 69. An analysis of systematic reviews undertaken on standard advanced wound dressings in the last 10 years.
    Horkan L; Stansfield G; Miller M
    J Wound Care; 2009 Jul; 18(7):298-304. PubMed ID: 19827483
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pseudoreplication conventions are testable hypotheses.
    Coss RG
    J Comp Psychol; 2009 Nov; 123(4):444-6. PubMed ID: 19929112
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The control group dilemma in clinical research: applications for psychosocial and behavioral medicine trials.
    Schwartz CE; Chesney MA; Irvine MJ; Keefe FJ
    Psychosom Med; 1997; 59(4):362-71. PubMed ID: 9251155
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expanding the evidence base in transplantation: more and better randomized trials, and extending the value of observational data.
    Craig JC; Webster AC; Mitchell A; Irwig L
    Transplantation; 2008 Jul; 86(1):32-5. PubMed ID: 18622275
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Solving problems with randomized clinical trials is not enough to improve psychotherapy outcome: comments on Krause.
    Lambert MJ
    Psychotherapy (Chic); 2011 Sep; 48(3):229-30; discussion 234-6. PubMed ID: 21875237
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Observational studies and randomized trials.
    Smith RP; Meier P
    N Engl J Med; 2000 Oct; 343(16):1196; author reply 1196-7. PubMed ID: 11041761
    [No Abstract]   [Full Text] [Related]  

  • 75. Guided by the research design: choosing the right statistical test.
    Beath A; Jones MP
    Med J Aust; 2018 Mar; 208(4):163-165. PubMed ID: 29490219
    [No Abstract]   [Full Text] [Related]  

  • 76. Methodological studies of systematic reviews: is there publication bias?
    Laupacis A
    Arch Intern Med; 1997 Feb; 157(3):357-8. PubMed ID: 9040305
    [No Abstract]   [Full Text] [Related]  

  • 77. Author's reply. Comments on 'On estimating treatment effects under non-compliance in randomized clinical trials: are intent-to-treat or instrumental variables analyses perfect solutions?' by Heejung Bang and Clarence E. Davis, Statistics in Medicine 2007; 26:954-964.
    Bang H; Davis CE
    Stat Med; 2009 Jun; 28(14):1967-8. PubMed ID: 19489015
    [No Abstract]   [Full Text] [Related]  

  • 78. Introduction: The perils of science in the world of policy and practice.
    Shadish WR
    Health Psychol; 2010 Mar; 29(2):105-6. PubMed ID: 20230081
    [No Abstract]   [Full Text] [Related]  

  • 79. The value of interrupted time-series experiments for community intervention research.
    Biglan A; Ary D; Wagenaar AC
    Prev Sci; 2000 Mar; 1(1):31-49. PubMed ID: 11507793
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of a common language effect size statistic.
    Björgvinsson T; Kerr P
    Am J Psychiatry; 1995 Jan; 152(1):151. PubMed ID: 7802111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.